Hepatic preservation with histidine-tryptophan-ketoglutarate solution in living-related and cadaveric liver transplantation

Clinical Science

Volumn 93, Issue 1, 1997, Pages 81-88

  Hatano, Etsuro ^a   Kiuchi, Tetsuya ^a,b   Tanaka, Akira ^a   Shinohara, Hisashi ^a   Kitai, Toshiyuki ^a   Satoh, Seiji ^a   Inomoto, Takuya ^a   Egawa, Hiroto ^a   Uemoto, Shinji ^a   Inomata, Yukihiro ^a   Lang, Hauke ^b   Oldhafer, Karl J ^b   Ringe, Bruckhardt ^b,c   Pichlmayr, Rudolf ^b   Tanaka, Koichi ^a   Yamaoka, Yoshio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Histidine tryptophan ketoglutarate solution; Liver; Transplantation

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR 5; HEMOGLOBIN; HTK SOLUTION; UNIVERSITY OF WISCONSIN SOLUTION;

ADULT; ARTICLE; BILE FLOW; CADAVER DONOR; CONTROLLED STUDY; HEPATIC ARTERY; HUMAN; HUMAN TISSUE; INFRARED SPECTROSCOPY; LIVER PRESERVATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; OXYGEN SATURATION; PORTAL VEIN; POSTOPERATIVE CARE; PRIORITY JOURNAL; REPERFUSION; TISSUE OXYGENATION; TISSUE PRESERVATION;

EID: 8544232811     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0930081     Document Type: Article

References (22)

1. Höscher M, Groenewoud AF. Current status of the HTK solution of Bretschneider in organ preservation. Transplant Proc 1991; 23: 2334-37.
2. Erhard J, Lange R, Scherer R, et al. Comparison of histidine-tryptophan-ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation: a prospective, randomized study. Transplant Int 1994; 7: 177-81.
3. Gubernatis G, Dietl KH, Kemnitz K, et al. Extended cold preservation time (20 hours 20 minutes) of a human liver graft by using cardioplegic HTK solution. Transplant Proc 1991; 23: 2408-9.
4. Belzer FO, D'alessandro AM, Hoffmann RM, et al. The use of UW solution in clinical transplantation: a 4-year experience. Ann Surg 1992; 215: 579-85.
5. Ozawa K, Uemoto S, Tanaka K, et al. An appraisal of pediatric liver transplantation from living relatives: initial clinical experiences in 20 pediatric liver transplantations from living relatives as donors. Ann Surg 1992; 216: 547-53.
6. Tanaka K, Uemoto S, Tokunaga Y, et al. Surgical techniques and innovations in living related liver transplantation. Ann Surg 1992; 217: 82-91.
7. Yamaoka Y, Ozawa K, Tanaka A, et al. New Devices for harvesting a hepatic graft from a living donor. Transplantation 1991; 52: 157-60.
8. Yamaoka Y, Morimoto T, Inamoto T, et al. Safety of the donor in living-related liver transplantation: an analysis of 100 parental donors. Transplantation 1995; 59: 224-6
9. Clavien PA, Harvey PRC, Strasberg SM. Preservation and reperfusion injuries in liver allografts: an overview and synthesis of current studies. Transplantation 1992; 53: 957-78.
10. Kiuchi T, Schlitt HJ, Oldhafer KJ, et al. Backgrounds of early intragraft immune activation and rejection in liver transplant recipients: impact of graft reperfusion quality. Transplantation 1995; 60: 49-55.
11. Kitai T, Tanaka A, Tokuka A, et al. Quantitative detection of hemoglobin saturation in the liver with near-infrared spectroscopy. Hepatology 1993; 18: 926-36.
12. Kitai T, Tanaka A, Tokuka A, et al. Intraoperative measurement of the graft oxygenation state in living related liver transplantation by near infrared spectroscopy. Transplant Int 1995; 8: 111-8.
13. Tanaka A, Tanaka K, Kitai T, et al. Living related liver transplantation across ABO blood groups: evaluation of hemodynamics with tissue near-infrared spectroscopy. Transplantation 1994; 58: 548-53.
14. Kiuchi T, Oldhafer KJ, Ringe B, et al. Tissue oxygen saturation of human hepatic grafts after reperfusion: paradoxical elevation in poor graft function. Transplant Int 1996; 9: 90-7.
15. Pichlmayr R, Bockhom WH, Neuhaus P. Lebertransplantation. In: Breitner B, ed. Chirurgische Operationslehre. Vol 6. Baltimore: Urban and Schwarzenberg, 1983: 1-19.
16. Inomata Y, Tanaka K, Egawa H, et al. The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. Transplantation 1996; 61: 247-52.
17. Schmidt ES, Schmidt FW. Glutamate dehydrogenase: biochemical and clinical aspects of an interesting enzyme. Clin Chim Acta 1988; 43: 43-56.
18. Tanaka A, Kitai T, Iwata S, et al. Delayed oxidation of intramitochondrial pyridine nucleotide oxidoreduction state as compared with tissue oxygenation in human liver transplantation. Biochim Biophys Acta 1993; 1182: 250-6.
19. Strasberg SM, Todo KH, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20: 829-38.
20. Moen J, Claesson K, Pienaar H, et al. Preservation of dog liver, kidney, and pancreas using the Beltzer-UW solution with a high-sodium and low-potassium content. Transplantation 1989; 47: 940-5.
21. Aminalai A, Kehrer G, Großmann F, Richter J, Bretschneider HJ. Morphological investigation of the porcine liver directly following preservation with Euro-Collins, University of Wisconsin and Bretchneider's HTK solution. Langenbecks Arch Chir 1989; 377: 81-8.
22. Van Gulik TM, Reinders ME, Nio R, Frederiks WM, Bosma A, Klopper PJ. Preservation of canine liver grafts using HTK solution. Transplantation 1994; 57: 167-71.